The U.S. Federal Trade Commission's "first-of-its-kind" enforcement action against U.S. health care company GoodRx has important takeaways for privacy programs that handle health-related data. It also signals an increase in the FTC's use of its unfairness authority in privacy cases, IAPP Managing Director, Washington, D.C., Cobun Zweifel-Keegan, CIPP/US, CIPM, and Westin Research Fellow Amy Olivero write. "As the FTC continues to strengthen its enforcement arsenal, this case stands as a cautionary tale for digital health companies — and any organization that processes sensitive personal data," they said.
Full Story